About Catamaran (NASDAQ:CTRX)
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Industry, Sector and Symbol
Industry Managed Health Care
Sub-IndustryHealth Care Services
Trailing P/E Ratio37.4817073170732
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity6.54%
Return on Assets4.25%
Catamaran (NASDAQ:CTRX) Frequently Asked Questions
What is Catamaran's stock symbol?
Catamaran trades on the NASDAQ under the ticker symbol "CTRX."
How were Catamaran's earnings last quarter?
Catamaran Corp (NASDAQ:CTRX) issued its earnings results on Thursday, February, 26th. The healthcare company reported $0.67 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.61 by $0.06. The healthcare company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.57 billion. Catamaran had a return on equity of 6.54% and a net margin of 1.66%. The company's quarterly revenue was up 26.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.56 EPS. View Catamaran's Earnings History.
Who are some of Catamaran's key competitors?
Some companies that are related to Catamaran include C R Bard (BCR), Essilor International (EI), Agilent Technologies (A), Cerner (CERN), Align Technology (ALGN), Iqvia (IQV), Teva Pharmaceutical Industries (TEVA), Incyte (INCY), Waters (WAT), Hospira (HSP), BioMarin Pharmaceutical (BMRN), Nektar Therapeutics (NKTR), Quest Diagnostics (DGX), Ramsay Health Care (RHC), Medivation (MDVN), CareFusion (CFN), Alnylam Pharmaceuticals (ALNY) and ABIOMED (ABMD).
How do I buy Catamaran stock?
Shares of Catamaran can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Catamaran's stock price today?
One share of Catamaran stock can currently be purchased for approximately $61.47.
How big of a company is Catamaran?
Catamaran has a market capitalization of $12.78 billion.
How can I contact Catamaran?
Catamaran's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The healthcare company can be reached via phone at +1-800-2823232.
MarketBeat Community Rating for Catamaran (CTRX)MarketBeat's community ratings are surveys of what our community members think about Catamaran and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Catamaran (NASDAQ:CTRX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Catamaran (NASDAQ:CTRX) Earnings History and Estimates Chart
Catamaran (NASDAQ CTRX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/30/2015||Q1||$0.57||$0.59||$5.73 billion||$5.98 billion||View||N/A|
|2/26/2015||Q414||$0.61||$0.67||$5.57 billion||$5.74 billion||View||N/A|
|10/30/2014||Q314||$0.56||$0.58||$5.36 billion||$5.50 billion||View||N/A|
|8/1/2014||Q214||$0.51||$0.54||$5.01 billion||$5.40 billion||View||N/A|
|5/1/2014||Q114||$0.44||$0.50||$4.68 billion||$4.90 billion||View||N/A|
|2/27/2014||Q413||$0.54||$0.56||$4.04 billion||$4.53 billion||View||N/A|
|10/31/2013||Q3 2013||$0.48||$0.52||$3.71 billion||$3.61 billion||View||N/A|
|8/1/2013||Q2 2013||$0.44||$0.49||$3.47 billion||$3.38 billion||View||N/A|
|5/2/2013||Q1 2013||$0.41||$0.42||$3.53 billion||$3.18 billion||View||N/A|
|2/28/2013||Q4 2012||$0.35||$0.39||$3.33 billion||$3.33 billion||View||N/A|
|11/1/2012||Q312||$0.24||$0.25||$3.25 billion||$3.15 billion||View||N/A|
Catamaran (NASDAQ:CTRX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Catamaran (NASDAQ:CTRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Catamaran (NASDAQ CTRX)
No insider trades for this company have been tracked by MarketBeat.com
Catamaran (NASDAQ CTRX) News Headlines
Catamaran (NASDAQ:CTRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Catamaran (NASDAQ:CTRX) Income Statement, Balance Sheet and Cash Flow Statement
Catamaran (NASDAQ CTRX) Stock Chart for Sunday, February, 25, 2018